Related Experiment Video
Updated: Feb 16, 2026

Super-resolution Imaging of Proteus mirabilis Biofilm by Expansion Microscopy
Published on: July 18, 2025
Increased mutability to fosfomycin resistance in Proteus mirabilis clinical isolates
Marina R B Fonseca1, Juliana L Sato1, Marco A Lima-Noronha1
1Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, SP, Brazil.
Abstract:
In the present study, we screened a collection of 77 Proteus mirabilis clinical isolates for the presence of mutators, using the frequency of both rifampicin and fosfomycin resistance mutants as markers of spontaneous mutagenesis. We found that none of the strains in our collection are mutators for the rifampicin resistance (RifR) marker. Nevertheless, a significant fraction of the isolates (17%) show high frequencies of fosfomycin resistant mutants (FosR). We show that this increased mutability to FosR correlates with a low level of resistance to Fosfomycin (MICs 8-64μg/ml). These strains also show high frequencies of single step mutants with clinically relevant FosR resistance levels (MIC ≥256μg/ml). Our findings point out to the risk of fosfomycin resistance emergence in P. mirabilis.
Insights
A study found that 17% of Proteus mirabilis clinical isolates exhibit high mutation rates for fosfomycin resistance. This suggests a significant risk for the emergence of fosfomycin resistance in P. mirabilis infections.
Area of Science:
- Microbiology
- Antimicrobial Resistance
- Clinical Infectious Diseases
Background:
- Proteus mirabilis is a common cause of urinary tract infections.
- Antimicrobial resistance is a growing global health concern.
- Fosfomycin is an important antibiotic for treating multidrug-resistant Gram-negative infections.
Purpose of the Study:
- To screen clinical isolates of Proteus mirabilis for mutator phenotypes.
- To assess the frequency of spontaneous mutations conferring resistance to rifampicin and fosfomycin.
- To evaluate the risk of fosfomycin resistance emergence in P. mirabilis.
Main Methods:
- Screening of 77 Proteus mirabilis clinical isolates.
- Utilizing rifampicin resistance (RifR) and fosfomycin resistance (FosR) mutant frequencies as markers for spontaneous mutagenesis.
- Determining minimum inhibitory concentrations (MICs) for fosfomycin resistance.
Main Results:
- No isolates showed mutator phenotypes for rifampicin resistance.
- 17% of isolates exhibited high frequencies of fosfomycin resistant mutants (FosR).
- Increased FosR mutability correlated with low-level fosfomycin resistance (MICs 8-64 μg/ml) and high frequencies of single-step mutants with clinically relevant resistance (MIC ≥256 μg/ml).
Conclusions:
- A notable fraction of P. mirabilis clinical isolates possess an elevated mutation rate towards fosfomycin resistance.
- These findings highlight a potential risk for the rapid emergence of clinically significant fosfomycin resistance in P. mirabilis.
- Further surveillance and understanding of resistance mechanisms are warranted.
Related Concept Videos
Development of Antibiotic Resistance
Mutations in Microorganisms
Gene Regulation in Microbial Communities: Quorum Sensing

